DOI: 10.12890/2020_001951

Acute Myocardial Infarction Secondary to Paradoxical Embolism

Authors

  • Abdullah R Alenezi Department of Cardiology, Chest Diseases Hospital, Kuwait City, Kuwait
  • Muath Alanbaei Department of Medicine, Faculty of Medicine, Kuwait University, Kuwait City, Kuwait
  • Islam Abouelenein Department of Cardiology, Chest Diseases Hospital, Kuwait City, Kuwait

drislamaboelenin@gmail.com

Keywords

Coronary artery, embolism, myocardial infarction, paradoxical embolism

Abstract

Patent foramen ovale is a risk factor for systemic embolic events such as cryptogenic stroke. Far less commonly, patent foramen ovale is associated with non-cerebral systemic embolic events. Paradoxical coronary artery embolism is a rare and underdiagnosed cause of acute myocardial infarction. It should be considered in patients presenting with myocardial infarction and an otherwise low-risk profile for atherosclerotic coronary artery disease. We describe a case of paradoxical coronary artery embolism causing ST elevation myocardial infarction. Echocardiography demonstrated patent foramen ovale with a significant shunt. In addition to the treatment of the acute coronary event, patent foramen ovale closure was performed to prevent recurrent paradoxical embolic events.

View the entire article

Downloads

References

  1. Calvert PA, Rana BS, Kydd AC, Shapiro LM. Patent foramen ovale: anatomy, outcomes, and closure. Nat Rev Cardiol 2011;8:148–160.
  2. Giblett JP, Abdul-Samad O, Shapiro LM, Rana BS, Calvert PA. Patent foramen ovale closure in 2019. Interv Cardiol 2019;14(1):34–41.
  3. Wilson AM, Ardehali R, Brinton RJ, Yeung AC, Vagelos R. Successful removal of a paradoxical coronary embolus using an aspiration catheter. Nat Clin Pract Cardiovasc Med 2006;3:633–636.
  4. Agewall S, Beltrame JF, Reynolds HR, Niessner A, Rosano G, Caforio ALP, et al. ESC working group position paper on myocardial infarction with non-obstructive coronary arteries. Eur Heart J 2017;38(3):143–153.
  5. Carroll JD, Saver JL, Thaler DE, Smalling RW, Berry S, MacDonald LA, et al. Closure of patent foramen ovale versus medical therapy after cryptogenic stroke. N Engl J Med 2013;368:1092–1100.
  6. Saver JL, Carroll JD, Thaler DE, Smalling RW, MacDonald LA, Marks DS, et al. Long-term outcomes of patent foramen ovale closure or medical therapy after stroke. N Engl J Med 2017;377:1022–1032.
  7. Søndergaard L, Kasner SE, Rhodes JF, Andersen G, Iversen HK, Nielsen-Kudsk JE, et al. Patent foramen ovale closure or antiplatelet therapy for cryptogenic stroke. N Engl J Med 2017;377:1033–1042.
  8. Lee PH, Song JK, Kim JS, Heo R, Lee S, Kim DH, et al. Cryptogenic stroke and high-risk patent foramen ovale: the DEFENSE-PFO trial. J Am Coll Cardiol 2018;71:2335–2342.

Published

2020-10-05

Issue

Vol. 7 No. 12 (2020)

How to Cite

1.
Alenezi AR, Alanbaei M, Abouelenein I. Acute Myocardial Infarction Secondary to Paradoxical Embolism. EJCRIM [Internet]. 2020 Oct. 5 [cited 2026 Nov. 3];7(12). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1951